Celebrating more than six decades of Making Cancer History?, The University of Texas M. D. Anderson Cancer Center is located in central Houston on the sprawling campus of the Texas Medical Center. It is one of the world’s most respect

ed centers devoted exclusively to cancer patient care, research, education and prevention.

M. D. Anderson Cancer Center was created in 1941 as a component of The University of Texas System. The institution is one of the nation’s original three comprehensive cancer centers designated by the National Cancer Act of 1971 and is one of 40 National Cancer Institute-designated comprehensive cancer centers today.

In 2009, U.S. News & World Report’s “America’s Best Hospitals” survey ranked M. D. Anderson as the top hospital in the nation for cancer care. M. D. Anderson has achieved the top ranking six times in the past eight years and has ranked as one of the top two hospitals for cancer care for 20 years, since the magazine began its annual survey in 1990.

Since 1944, nearly 800,000 patients have turned to M. D. Anderson for cancer care in the form of surgery, chemotherapy, radiation therapy, immunotherapy, or combinations of these and other treatments. This multidisciplinary approach to treating cancer was pioneered at M. D. Anderson. Because its experts focus on cancer, they are renowned for their ability to treat all types of cancer, including rare or uncommon diseases.








At M. D. Anderson, important scientific knowledge gained in the laboratory is rapidly translated into clinical care. In FY08, the institution invested more than $488 million in research, an increase of about 56 percent in the past five years.

M. D. Anderson ranks first in the number of research grants awarded and total amount of grants given by the NCI. The institution holds 11 NCI grants: brain, breast, genitourinary, head and neck, leukemia, lung, melanoma, ovarian, pancreatic, prostate, uterine. The research program is considered one of the most productive efforts in the world aimed solely at cancer.

M. D. Anderson is expanding its research endeavors with the creation of the McCombs Institute for the Early Detection and Treatment of Cancer. The institute comprises six translational research centers focused on genomics, proteomics, screening, diagnostic imaging and drug development. Located on the 116-acre University of Texas Research Park, about 1.5 miles south of the North Campus, the McCombs Institute will house about 25 percent of M. D. Anderson’s research activities. Four programs are in operation: the Proton Therapy Center, the Cancer Metastasis Research Center, the Center for Cancer Immunology Research and the Kleberg Center for Molecular Markers.


       科研方面:2006年,该中心对科研的投资超过4.1亿美元,并在过去的五年中增加了约95 %的投资。 MDACC申请到NCI基金排名第一 。MDACC所拥有10个专业领域的NCI研究基金:膀胱癌,乳腺癌,子宫内膜,头部和颈部,白血病,肺癌,黑色素瘤,卵巢癌,胰腺癌,前列腺癌。这些研究项目是针对癌症最有成效的研究。2005年9月, MDACC宣布建立用于研究早期发现和早期治疗癌症的研究所。该研究所由六个独特的中心集中在基因组学,蛋白质组学,筛选,诊断成像,生物技术和质子治疗。坐落在116英亩的得克萨斯大学研究园约1.5公里的主校区。


In FY08, almost 6,000 students, including physicians, scientists, nurses and allied health professionals, took part in M. D. Anderson educational programs. The institution’s School of Health Professions offers bachelor’s degrees in seven allied health disciplines.

More than 1,000 clinical residents and fellows come to M. D. Anderson each year to receive specialized training in the investigation and treatment of cancer. More than 500 graduate students are working on advanced degrees at the Graduate School of Biomedical Sciences, which M. D. Anderson operates jointly with The University of Texas Health Science Center at Houston. More than 1,500 research fellows are being trained in M. D. Anderson’s laboratories.

Thousands more participate in continuing education and distance learning opportunities sponsored by M. D. Anderson, sharing knowledge around the globe. M. D. Anderson provides public education programs to teach healthy people about cancer symptoms and risk factors, giving them information that one day might aid them in making critical health care decisions.


       教育方面:每年超过4300学生在MDACC接受教育,其中包括医生,科学家,护士和许多保健专业人员。每年超过1000名临床医师来MDACC接受专门的培训。 500多名本科毕业生为了获得更高的学位来MDACC学习。另外每年有超过1300名的研究人员在MDACC的实验室中接受培训。


With faculty and staff working in more than 25 buildings in Houston and central Texas, M. D. Anderson is one of the largest cancer centers in the world. The physical plant includes an inpatient pavilion with 507 beds, five research buildings, three outpatient clinic buildings, two faculty office buildings, a proton radiation clinic building and a patient-family hotel. Since 2005, the Mitchell Basic Sciences Research Building, the Mays Clinic, the Duncan Family Institute for Cancer Prevention, the Saberioon Molecular Markers Research Building, the Proton Therapy Center and the Pickens Academic Tower have opened. An ongoing expansion of Alkek Hospital will accommodate about 200 additional inpatient beds, adding nine floors to its current 12.


       医院设施:MDACC在休斯顿和得克萨斯州中部拥有25栋楼。MDACC是世界上最大的癌症中心之一。 住院部有521张病床,五个研究楼,三个门诊大楼,一栋员工楼,质子放射治疗中心和为病人服务的家庭式酒店。从2005年到现在,米切尔基础科学和研究大楼,梅斯诊所,癌症预防大楼, 分子标记研究大楼和质子治疗中心相继投入使用。2008年皮肯斯学术大楼开业其中包括额外的教学和行政空间,同时不断对医院主楼进行扩建,届时将增加200张住院病床,增加9个楼层。有17000名员工。


The Institute Gustave-Roussy (IGR), the leading European anticancer centre, assembles on the same site 2,500 men  and women whose missions are to treat patients suffering from cancer, conduct research and develop new therapies, and to pass on knowledge and know-how to the medical and scientific communities in France and world-wide.

In the 400-bed hospital with its 124 statutory physicians, annually over 11,000 new patients are recruited, 130,000 patie

nts attend its clinics and 42,000 patients receive treatment.

Research is conducted by 400 research scientists under the oversight of a scientific council, a therapeutic trials commiss

ion and a clinical research committee.

Situated in the heart of Europe, at the gateway to Paris, the Institute Gustave-Roussy is poised to undergo thorough restructuring and renovation at the beginning of the 21st century, to enhance its efficacy in its primary commitment towards patients, the fight against cancer.


       法国Gustave-Roussy肿瘤医院和癌症研究所是欧洲最大的癌症研究机构,坐落于欧洲的中心——巴黎. 该中心主要致力于癌症病人的治疗,癌症治疗最新技术的研发和推广. 目前拥有2500名员工、病床数为400、 新病患人数为11000、门诊病患数:130000、有42000名患者得到治疗。有14个附属的研究实验室、300多临床试验项目。


National Healthcare Group, in its efforts to help Singapore fight cancer, established The Cancer Institute (TCI) in the ye

ar 2000, to provide comprehensive cancer management programs - from prevention to recovery and long-term health maintenance.




友情链接:秒速牛牛登陆  官方快乐赛车  北京快乐8官网  幸运赛车app下载地址  秒速快3开奖结果  北京快乐8官网开奖记录  秒速pk10玩法技巧  pc加拿大官网app  极速飞艇app  重庆时时历史记录